US Executive Compensation Proxy SEC Filings — May 07, 2026

07-05-2026

Wave Life Sciences Ltd. (Wave-Singapore) is seeking shareholder approval via a proxy statement for a scheme of arrangement to redomicile its ultimate parent from Singapore to Delaware, forming Wave Life Sciences, Inc. (Wave-Delaware) as the new publicly traded parent through a one-for-one exchange of ordinary shares, with the board unanimously recommending approval for benefits like administrative efficiencies and Delaware's favorable corporate laws. The special meeting is scheduled for June 22, 2026, with a record date of April 27, 2026, when 192,402,202 ordinary shares were outstanding held by 150 scheme shareholders; however, risks include changes in shareholder rights under Delaware law versus Singapore law.

• ·Quorum at Special Meeting requires presence of at least two Scheme Shareholders holding a majority of outstanding ordinary shares.
• ·Approval of Wave Redomiciliation Proposal requires (i) majority in number of Scheme Shareholders present and voting, and (ii) at least 75% of shares held by those present and voting.
• ·Implementation Agreement dated April 15, 2026.
• ·Special Meeting location: 733 Concord Avenue, Cambridge, MA 02138, at 1:00 p.m. Eastern time on June 22, 2026.

07-05-2026

Designer Brands Inc. (DBI) filed its DEF 14A Proxy Statement on May 7, 2026, for the virtual 2026 Annual Meeting of Shareholders on June 17, 2026 (record date April 23, 2026), proposing election of four Class I directors to serve until 2029, ratification of Deloitte & Touche LLP as FY2026 auditors, advisory approval of FY2025 named executive officer compensation, and multiple amendments to the Code of Regulations including enhanced advance notice procedures and voting standard changes. CEO Douglas M. Howe noted FY2025 progress in business transformation, including elevated assortment, inventory productivity gains, a new DSW brand positioning campaign, and Brand Portfolio profitability improvements despite tariff challenges, alongside FY2026 organizational changes and new CFO Sheamus Toal appointment. No quantitative declines or flat metrics were disclosed.

• ·2026 Annual Meeting: June 17, 2026 at 1:00 p.m. ET, virtual-only at www.virtualshareholdermeeting.com/DBI2026
• ·Voting: One vote per Class A share, eight votes per Class B share
• ·Proxy materials distributed beginning May 7, 2026, including 2025 Form 10-K

07-05-2026

Capstone Holding Corp.'s DEF 14A proxy statement for the 2026 Annual Meeting discloses 14,435,905 shares of Common Stock outstanding as of April 22, 2026, with directors and executive officers as a group beneficially owning 5,671,535 shares (39.29%) and controlling 48.12% of voting power. CEO Matthew E. Lipman holds the largest stake at 3,048,436 shares (21.12%, 26.77% voting power), followed by BPA XIV, LLC at 2,528,662 shares (17.52%). The Board nominates Fredric J. Feldman, Ph.D. and Elwood D. Howse, Jr. as Class I directors (one-year terms) and John M. Holliman, III and Gordon Strout as Class II directors (until 2028).

• ·Class I director nominees: Fredric J. Feldman, Ph.D. (age 86) and Elwood D. Howse, Jr. (age 86) for one-year terms.
• ·Class II director nominees: John M. Holliman, III (age 73) and Gordon Strout (age 63) for terms until 2028.
• ·Class III continuing directors: Michael Toporek, Matthew E. Lipman, Charles Dana (terms until 2027 Annual Meeting).
• ·Voting power includes 985,063 votes from Series B Preferred Stock (Nectarine Management LLC) and 1,467,532 votes from Series Z Preferred Stock.

07-05-2026

Core & Main, Inc. (CNM) filed its DEF 14A Proxy Statement on May 7, 2026, for the virtual annual shareholder meeting on June 23, 2026, at 9:00 a.m. Central Time. Shareholders of record as of April 27, 2026, will vote on electing three Class II directors for three-year terms expiring in 2029, ratifying PricewaterhouseCoopers LLP as independent auditor for fiscal 2026 (ending January 31, 2027), and an advisory vote approving NEO compensation for fiscal 2025 (ended February 1, 2026). The proxy references the FY2025 Form 10-K filed March 24, 2026, and highlights compensation disclosures for PEOs including Stephen O. LeClair and Mark R. Witkowski.

• ·Annual Meeting virtual access: www.virtualshareholdermeeting.com/CNM2026
• ·Fiscal periods referenced: FY2025 (2025-02-03 to 2026-02-01), FY2024 (2024-01-29 to 2025-02-02), FY2023 (2023-01-30 to 2024-01-28), FY2022 (2022-01-31 to 2023-01-29), FY2021 (2021-02-01 to 2022-01-30)
• ·Class A and Class B common stock: one vote per share; Class B non-economic but exchangeable for Class A via Exchange Agreement dated July 22, 2021
• ·Proxy materials available at www.proxyvote.com

07-05-2026

Fluent, Inc. (FLNT) filed a DEF 14A Proxy Statement on May 07, 2026, marked as Definitive Additional Materials by the registrant. The filing indicates no fee was required. No substantive proxy details, such as proposals or executive compensation, are provided in the available content.

• ·Filing Type: DEF 14A (Schedule 14A pursuant to Section 14(a) of the Securities Exchange Act of 1934)
• ·Filed by the Registrant
• ·Payment of Filing Fee: No fee required

07-05-2026

This proxy statement seeks shareholder approval for the election of three trustees to the Board of each of the John Hancock Marathon Asset-Based Lending Fund, Manulife Private Credit Plus Fund, John Hancock CQS Multi Asset Credit Fund, and John Hancock CQS Asset Backed Securities Fund at a special joint meeting on June 18, 2026. JH Marathon Fund shareholders are additionally asked to approve a new subadvisory agreement with Marathon Asset Management, LP, necessitated by Marathon's acquisition by affiliates of CVC Capital Partners plc in January 2026, with no changes to the portfolio team or operations. The Board unanimously recommends voting 'FOR' both proposals, noting no expected material impact on fund management or objectives.

• ·Shareholder record date: March 23, 2026
• ·Meeting details: June 18, 2026, at 2:00 P.M. Eastern Time, 200 Berkeley Street, Boston, Massachusetts 02116
• ·Marathon acquisition announcement: January 2026
• ·Fund former name change date: September 30, 2021

07-05-2026

This DEF 14A proxy statement solicits shareholder votes for the election of three trustees to the Board of each Fund, including Manulife Private Credit Plus Fund, at a special joint meeting on June 18, 2026. Shareholders of the John Hancock Marathon Asset-Based Lending Fund are additionally asked to approve a new subadvisory agreement with Marathon Asset Management, LP, required due to its acquisition by affiliates of CVC Capital Partners plc announced in January 2026, ensuring management continuity with no changes to the portfolio team or operations. The Board unanimously recommends voting FOR both proposals, stating they will have no material effect on fund management or investment objectives.

• ·Shareholder record date: March 23, 2026
• ·Meeting location: 200 Berkeley Street, Boston, Massachusetts 02116, at 2:00 P.M. Eastern Time
• ·Marathon acquisition announcement: January 2026
• ·Filer CIK: 0001988855; EIN: 932429100; State of Incorporation: MA; Fiscal Year End: 1231
• ·Proxy voting options: online (www.proxyvotenow.com/jh0626 or per card), phone (877-759-2811 or per card), mail

07-05-2026

This DEF 14A proxy statement solicits votes from shareholders of John Hancock CQS Multi Asset Credit Fund and affiliated funds for the election of three trustees at a special joint meeting on June 18, 2026; all shareholders vote on this routine proposal with no expected material changes to fund operations. Shareholders of the John Hancock Marathon Asset-Based Lending Fund are additionally asked to approve a new subadvisory agreement with Marathon Asset Management, LP, required due to its acquisition by CVC Capital Partners affiliates in January 2026, ensuring management continuity without changes to the portfolio team. The Board unanimously recommends voting 'FOR' both proposals.

• ·Record date for shareholders entitled to vote: March 23, 2026
• ·Meeting location: 200 Berkeley Street, Boston, Massachusetts 02116 at 2:00 P.M. Eastern Time on June 18, 2026
• ·Fiscal year end: October 31
• ·Marathon name change date: January 18, 2024
• ·No fee required for filing; payment of filing fee checked as 'No fee required'

07-05-2026

The proxy statement solicits votes for a special joint shareholder meeting on June 18, 2026, for all Funds including John Hancock CQS Asset Backed Securities Fund, primarily to elect three trustees to each Fund's Board (Proposal 1, applicable to all Funds). Shareholders of John Hancock Marathon Asset-Based Lending Fund will also vote on approving a new subadvisory agreement with Marathon Asset Management, LP due to its acquisition by CVC Capital Partners affiliates (Proposal 2). The Board unanimously recommends voting FOR both proposals, noting no expected material changes to Fund management or objectives.

• ·Record date for shareholders entitled to vote: March 23, 2026
• ·Meeting location: 200 Berkeley Street, Boston, Massachusetts 02116 at 2:00 P.M. Eastern Time
• ·Proxy materials available at: https://www.jhinvestments.com/resources/all-resources/fund-documents/proxy-documents/john-hancock-spring-2026-proxy-statement
• ·Voting methods: online (www.proxyvotenow.com/jh0626), phone (877-759-2811), or mail

07-05-2026

CXApp Inc., a former SPAC that merged with Legacy CXApp in March 2023, has issued a proxy statement for its 2026 Annual Meeting on June 16, 2026 (virtual), seeking approval for electing directors, issuing shares under Nasdaq 20% rule, reverse stock split and charter amendment, advisory votes on executive compensation (including frequency), and auditor ratification. As of the record date April 17, 2026, 69,015,433 shares of common stock are outstanding, with quorum requiring at least 23,005,145 shares; no financial performance data or period comparisons are detailed in the provided content.

• ·Annual Meeting: June 16, 2026 at 2 P.M. Pacific Time, virtual at www.virtualshareholdermeeting.com/CXAI2026
• ·Proxy materials first mailed on or about May 7, 2026
• ·Merger with Legacy CXApp closed March 14, 2023 pursuant to September 25, 2022 Merger Agreement
• ·Proposals include approval of reverse stock split and charter amendment, and share issuance under Nasdaq 20% rule

07-05-2026

Lakeland Industries, Inc. has filed a definitive proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 16, 2026, at 9:00 a.m. CDT, with a record date of April 20, 2026. Shareholders are asked to vote on electing three directors for three-year terms, ratifying RSM US LLP as independent auditors for the fiscal year ending January 31, 2027, approving on an advisory basis the compensation of named executive officers, and approving the 2026 Equity Incentive Plan. As of the record date, 9,857,703 shares of common stock were outstanding.

• ·Annual Meeting is virtual only at www.proxydocs.com/LAKE.
• ·Principal executive offices: 1525 Perimeter Parkway, Suite 325, Huntsville, AL 35806.
• ·Proxy materials first sent on or about May 7, 2026.

07-05-2026

Okta, Inc.'s DEF 14A Proxy Statement for the 2026 Annual Meeting on June 18, 2026, seeks stockholder approval to elect two Class III directors (Anthony Bates and David Schellhase), ratify Ernst & Young LLP as independent auditors for FY2027, approve NEO compensation on an advisory basis, and amend the 2017 Equity Incentive Plan. CEO Todd McKinnon highlights the company's transformation for the AI agent era, board strengthening with three new independent directors, and retirements of three long-serving directors. No performance declines or flat metrics are disclosed in the provided content.

• ·Record Date: April 22, 2026
• ·Annual Meeting: June 18, 2026, at 9:00 a.m. Pacific Time, virtually at virtualshareholdermeeting.com/OKTA2026
• ·Board structure: Staggered three classes; Class III term expires 2029 if elected
• ·Three new independent directors added; three directors retiring

07-05-2026

SurgePays, Inc. (SURG) filed a DEF 14A proxy statement dated May 07, 2026, for its 2026 annual meeting of stockholders, seeking shareholder approval to elect four director nominees (Kevin Brian Cox, David N. Keys, David May, and Laurie Weisberg), ratify TAAD, LLP as independent auditors for the fiscal year ending December 31, 2026, and approve securities purchase agreements with institutional investors from 2025-2026 involving issuance of common stock equal to 20% or more of outstanding shares. As of the record date May 5, 2026, 25,121,895 shares of common stock were issued and outstanding. The Board unanimously recommends voting 'FOR' all proposals; no financial performance metrics or period-over-period comparisons are detailed in the provided content.

• ·Record Date: May 5, 2026
• ·Annual Meeting virtual registration opens June 16, 2026, at 11:45 A.M. Pacific Time at www.virtualshareholdermeeting.com/SURG2026
• ·Proxies appointed: Kevin Brian Cox and Chelsea Pullano
• ·Proposal 3 involves approval of share issuances to institutional investors equal to 20% or more of outstanding common stock (non-routine matter requiring shareholder approval)

07-05-2026

Highland Opportunities and Income Fund's proxy statement solicits votes from Preferred Shareholders for the re-election of Dr. Bob Froehlich as Class II Trustee for a three-year term at the Annual Meeting on June 16, 2026. The Board, composed of four Independent Trustees, recommends a vote FOR the proposal, with no dividend arrearages on Preferred Shares. As of the April 30, 2026 Record Date, 55,406,502 Common Shares, 5,800,000 Series A Preferred Shares, and 4,000,000 Series B Preferred Shares are outstanding.

• ·Record Date: close of business on April 30, 2026
• ·Annual Meeting location: 300 Crescent Court, Suite 700, Dallas, Texas 75201, at 8:30 a.m. Central Time
• ·Quorum requirement: presence of holders of 33 1/3% of shares entitled to vote
• ·Vote required: plurality of Preferred Shares voting as a separate class
• ·Proxy materials available online at https://proxyvotinginfo.com/p/hfro2026

07-05-2026

Highland Global Allocation Fund's proxy statement solicits shareholder votes for the Annual Meeting on June 16, 2026, at 8:45 a.m. CT in Dallas, TX, primarily to re-elect Dr. Bob Froehlich as a Class II Trustee for a three-year term expiring in 2029. The record date is April 30, 2026, with 23,590,445 common shares outstanding, requiring a plurality vote for election and a 33 1/3% quorum. The Board, consisting of four Independent Trustees, unanimously recommends voting FOR the proposal; no other matters are anticipated.

• ·Fund is a closed-end management investment company under the 1940 Act.
• ·Adviser: NexPoint Asset Management, L.P.
• ·Proxy materials available online at https://proxyvotinginfo.com/p/gaf2026.
• ·Voting methods: internet, phone, or mail using control number on proxy card.